Researchers at Mayo Clinic have found that a mild to moderate reduction in calories effectively prevents and reverses polycystic kidney disease (PKD) in mice. The results appear online in the Journal of the American Society ...
Nov 24, 2015
0
10
(Medical Xpress)—Researchers at King's College London's Dental Institute have shown that people with a certain kind of kidney disease have characteristic facial features that may reflect the genetic mutation they carry.
Apr 24, 2013
1
0
A new method to create kidney organoids from patient cells may provide insights into how kidney diseases arise and how they should be treated. The research will be presented at ASN Kidney Week 2016 November 15¬-20 at McCormick ...
Nov 17, 2016
0
0
Yale researchers are studying kidney and liver diseases to determine which genes are involved in the formation of cysts.
Apr 6, 2017
0
25
The protein known as polycystin 2 is present in every cell in the body, but until now scientists knew little about its purpose. Yale researchers have discovered that it protects against cell death, making it a potential target ...
Feb 6, 2020
0
71
New research has uncovered a process that is defective in patients with autosomal dominant polycystic kidney disease, a common cause of kidney failure. The findings, which appear in an upcoming issue of the Journal of the ...
Sep 5, 2013
0
0
A growing cohort of talented Northwestern Medicine scientists is working to unlock the secrets of ion channels and discover how these tiny molecular machines contribute to an array of diseases, from brain tumors and epilepsy ...
Sep 1, 2017
0
23
Autosomal dominant polycystic kidney disease (ADPKD), a genetic disorder, causes fluid-filled cysts to develop on the kidneys, which can impair their function. As part of the growth of cysts, the kidneys develop inflammation ...
Oct 13, 2021
0
76
A new study published today in British Journal of Pharmacology has identified that a component of grapefruit and other citrus fruits, naringenin, successfully blocks the formation of kidney cysts.
Oct 3, 2013
0
0
(HealthDay)—Patients who take Samsca (tolvaptan) may be at elevated risk for significant liver injury, according to a Jan. 25 safety alert issued by the U.S. Food and Drug Administration.
Jan 26, 2013
0
0
